ArticleClinical diabetes and endocrinology2024

Application of a validated prognostic plasma protein biomarker test for renal decline in type 2 diabetes to type 1 diabetes: the Fremantle Diabetes Study Phase II.

Timothy M E Davis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.